Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-Aug-24 6:35 PM View:  | MacKaness James H Chief Financial Officer | Soleno Therapeutics Inc (SLNO) | 29-Aug-24 | Sale | 6,870 | $47.28 | $324,845.00 | (5%) 134.12K to 127.25K | |
| 30-Aug-24 6:34 PM View: | Hirano Patricia C See Remarks | Soleno Therapeutics Inc (SLNO) | 29-Aug-24 | Sale | 5,435 | $47.28 | $256,992.00 | (5%) 117.47K to 112.04K | |
| 29-Aug-24 7:36 PM View: | Vivo Opportunity, LLC 10% Owner | Soleno Therapeutics Inc (SLNO) | 29-Aug-24 | Sale | 100,000 | $47.22 | $4,722,000.00 | (2%) 6.39M to 6.29M | |
| 30-Aug-24 6:33 PM View: | Anish Bhatnagar Chief Executive Officer Director | Soleno Therapeutics Inc (SLNO) | 29-Aug-24 | Sale | 58,391 | $47.28 | $2,760,990.00 | (7%) 799.58K to 741.19K | |
| 30-Aug-24 6:36 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 29-Aug-24 | Sale | 5,435 | $47.28 | $256,992.00 | (6%) 90.01K to 84.57K | |
| 29-Aug-24 7:36 PM View: | Vivo Opportunity, LLC 10% Owner | Soleno Therapeutics Inc (SLNO) | 28-Aug-24 | Sale | 425,000 | $47.35 | $20,123,800.00 | (6%) 6.82M to 6.39M | |
| 30-Aug-24 6:33 PM View: | Anish Bhatnagar Chief Executive Officer Director | Soleno Therapeutics Inc (SLNO) | 28-Aug-24 | Private Sale | 56,613 | $47.58 | $2,693,710.00 | (7%) 856.19K to 799.58K | |
| 30-Aug-24 6:36 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 28-Aug-24 | Private Sale | 5,270 | $47.58 | $250,753.00 | (6%) 95.28K to 90.01K | |
| 30-Aug-24 6:35 PM View: | MacKaness James H Chief Financial Officer | Soleno Therapeutics Inc (SLNO) | 28-Aug-24 | Private Sale | 6,661 | $47.58 | $316,938.00 | (5%) 140.78K to 134.12K | |
| 30-Aug-24 6:34 PM View: | Hirano Patricia C See Remarks | Soleno Therapeutics Inc (SLNO) | 28-Aug-24 | Private Sale | 5,270 | $47.58 | $250,753.00 | (4%) 122.75K to 117.47K | |
| 29-Aug-24 7:36 PM View: | Vivo Opportunity, LLC 10% Owner | Soleno Therapeutics Inc (SLNO) | 27-Aug-24 | Private Sale | 500,000 | $48.73 | $24,365,000.00 | (7%) 7.32M to 6.82M | |
| 16-Aug-24 6:18 PM View: | Bir Dawn Carter Director | Soleno Therapeutics Inc (SLNO) | 15-Aug-24 | Grant | 13,000 | -- | -- | 100% 0 to 13.0K | |
| 07-Aug-24 6:57 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 06-Aug-24 | Sale | 5,957 | $45.46 | $270,780.00 | (6%) 101.23K to 95.28K | |
| 07-Aug-24 6:56 PM View: | MacKaness James H Chief Financial Officer | Soleno Therapeutics Inc (SLNO) | 06-Aug-24 | Sale | 8,134 | $45.46 | $369,736.00 | (5%) 148.91K to 140.78K | |
| 07-Aug-24 6:56 PM View: | Hirano Patricia C See Remarks | Soleno Therapeutics Inc (SLNO) | 06-Aug-24 | Sale | 5,977 | $45.46 | $271,689.00 | (5%) 128.72K to 122.75K | |
| 07-Aug-24 6:55 PM View: | Anish Bhatnagar Chief Executive Officer Director | Soleno Therapeutics Inc (SLNO) | 06-Aug-24 | Sale | 69,131 | $45.46 | $3,142,400.00 | (7%) 925.32K to 856.19K | |
| 07-Aug-24 6:56 PM View: | MacKaness James H Chief Financial Officer | Soleno Therapeutics Inc (SLNO) | 05-Aug-24 | Private Sale | 6,849 | $45.77 | $313,466.00 | (4%) 155.76K to 148.91K | |
| 07-Aug-24 6:56 PM View: | Hirano Patricia C See Remarks | Soleno Therapeutics Inc (SLNO) | 05-Aug-24 | Private Sale | 5,032 | $45.77 | $230,305.00 | (4%) 133.75K to 128.72K | |
| 07-Aug-24 6:55 PM View: | Anish Bhatnagar Chief Executive Officer Director | Soleno Therapeutics Inc (SLNO) | 05-Aug-24 | Private Sale | 58,213 | $45.77 | $2,664,300.00 | (6%) 983.53K to 925.32K | |
| 07-Aug-24 6:57 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 05-Aug-24 | Private Sale | 5,017 | $45.77 | $229,618.00 | (5%) 106.25K to 101.23K | |
| 19-Jul-24 9:03 AM View: | Huang Michael F. Sr. VP of Clinical Development | Soleno Therapeutics Inc (SLNO) | 17-Jul-24 | Grant | 35,000 | -- | -- | 100% 0 to 35.0K | |
| 19-Jul-24 9:02 AM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 17-Jul-24 | Grant | 85,000 | -- | -- | 400% 21.25K to 106.25K | |
| 19-Jul-24 9:01 AM View: | MacKaness James H Chief Financial Officer | Soleno Therapeutics Inc (SLNO) | 17-Jul-24 | Grant | 100,000 | -- | -- | 179% 55.76K to 155.76K | |
| 19-Jul-24 9:04 AM View: | Manning Meredith Chief Commercial Officer | Soleno Therapeutics Inc (SLNO) | 17-Jul-24 | Grant | 40,000 | -- | -- | 100% 0 to 40.0K | |
| 19-Jul-24 9:02 AM View: | Hirano Patricia C See Remarks | Soleno Therapeutics Inc (SLNO) | 17-Jul-24 | Grant | 85,000 | -- | -- | 174% 48.75K to 133.75K | |
| 19-Jul-24 9:00 AM View: | Anish Bhatnagar Chief Executive Officer Director | Soleno Therapeutics Inc (SLNO) | 17-Jul-24 | Grant | 850,000 | -- | -- | 637% 133.53K to 983.53K | |
| 03-Jul-24 5:56 PM View: | Anish Bhatnagar Chief Executive Officer Director | Soleno Therapeutics Inc (SLNO) | 01-Jul-24 | Private Sale | 19,256 | $41.54 | $799,844.00 | (13%) 152.79K to 133.53K | |
| 03-Jul-24 6:00 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 01-Jul-24 | Private Sale | 2,170 | $41.54 | $90,136.20 | (9%) 23.42K to 21.25K | |
| 03-Jul-24 5:58 PM View: | MacKaness James H Chief Financial Officer | Soleno Therapeutics Inc (SLNO) | 01-Jul-24 | Private Sale | 7,190 | $41.54 | $298,654.00 | (11%) 62.95K to 55.76K | |
| 03-Jul-24 5:58 PM View: | Hirano Patricia C See Remarks | Soleno Therapeutics Inc (SLNO) | 01-Jul-24 | Private Sale | 2,170 | $41.54 | $90,136.20 | (4%) 50.92K to 48.75K | |
| 10-Jun-24 8:46 PM View: | Harris William G Director | Soleno Therapeutics Inc (SLNO) | 06-Jun-24 | Grant | 6,500 | -- | -- | 73% 8.9K to 15.4K | |
| 10-Jun-24 8:51 PM View: | Sinclair Andrew Director | Soleno Therapeutics Inc (SLNO) | 06-Jun-24 | Grant | 6,500 | -- | -- | 100% 0 to 6.5K | |
| 10-Jun-24 8:52 PM View: | Volck Birgitte Director | Soleno Therapeutics Inc (SLNO) | 06-Jun-24 | Grant | 6,500 | -- | -- | 92% 7.04K to 13.54K | |
| 10-Jun-24 8:50 PM View: | Pauls Matthew Director | Soleno Therapeutics Inc (SLNO) | 06-Jun-24 | Grant | 6,500 | -- | -- | 100% 0 to 6.5K | |
| 10-Jun-24 8:49 PM View: | Mario Ernest Director | Soleno Therapeutics Inc (SLNO) | 06-Jun-24 | Grant | 6,500 | -- | -- | 3% 208.35K to 214.85K | |
| 23-May-24 10:00 PM View: | Mario Ernest Director | Soleno Therapeutics Inc (SLNO) | 21-May-24 | Exercise (in-the money or at-the-money) | 62,000 | $4.50 | $279,000.00 | 42% 146.35K to 208.35K | |
| 01-May-24 1:10 PM View: | Vivo Opportunity, LLC 10% Owner | Soleno Therapeutics Inc (SLNO) | 30-Apr-24 | Sale | 351,242 | $45.13 | $15,851,600.00 | (5%) 7.67M to 7.32M | |
| 01-May-24 1:10 PM View: | Vivo Opportunity, LLC 10% Owner | Soleno Therapeutics Inc (SLNO) | 29-Apr-24 | Private Sale | 750,000 | $47.80 | $35,850,000.00 | (9%) 8.42M to 7.67M | |
| 03-Apr-24 9:39 PM View: | MacKaness James H Chief Financial Officer | Soleno Therapeutics Inc (SLNO) | 01-Apr-24 | Private Sale | 5,175 | $41.34 | $213,937.00 | (8%) 68.13K to 62.95K | |
| 03-Apr-24 9:37 PM View: | Hirano Patricia C See Remarks | Soleno Therapeutics Inc (SLNO) | 01-Apr-24 | Private Sale | 2,218 | $41.34 | $91,693.60 | (4%) 53.14K to 50.92K | |
| 03-Apr-24 9:36 PM View: | Anish Bhatnagar Chief Executive Officer Director | Soleno Therapeutics Inc (SLNO) | 01-Apr-24 | Private Sale | 18,980 | $41.34 | $784,645.00 | (11%) 171.77K to 152.79K | |
| 03-Apr-24 9:40 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 01-Apr-24 | Private Sale | 2,218 | $41.34 | $91,693.60 | (9%) 25.64K to 23.42K | |
| 29-Jan-24 5:42 PM View: | Anish Bhatnagar Chief Executive Officer Director | Soleno Therapeutics Inc (SLNO) | 25-Jan-24 | Private Sale | 2,527 | $48.30 | $122,054.00 | (1%) 174.3K to 171.77K | |
| 29-Jan-24 5:47 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 25-Jan-24 | Private Sale | 397 | $48.30 | $19,175.10 | (2%) 26.04K to 25.64K | |
| 29-Jan-24 5:44 PM View: | Hirano Patricia C See Remarks | Soleno Therapeutics Inc (SLNO) | 25-Jan-24 | Private Sale | 832 | $48.30 | $40,185.60 | (2%) 43.97K to 43.14K | |
| 10-Jan-24 4:31 PM View: | Mario Ernest Director | Soleno Therapeutics Inc (SLNO) | 08-Jan-24 | Gift | 3,523 | -- | -- | (2%) 148.84K to 145.32K | |
| 08-Jan-24 5:34 PM View: | Anish Bhatnagar Chief Executive Officer Director | Soleno Therapeutics Inc (SLNO) | 04-Jan-24 | Grant | 150,000 | -- | -- | 617% 24.3K to 174.3K | |
| 08-Jan-24 5:36 PM View: | MacKaness James H Chief Financial Officer | Soleno Therapeutics Inc (SLNO) | 04-Jan-24 | Grant | 56,000 | -- | -- | 462% 12.13K to 68.13K | |
| 08-Jan-24 5:37 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 04-Jan-24 | Grant | 24,000 | -- | -- | 1178% 2.04K to 26.04K | |
| 08-Jan-24 5:35 PM View: | Hirano Patricia C See Remarks | Soleno Therapeutics Inc (SLNO) | 04-Jan-24 | Grant | 24,000 | -- | -- | 120% 19.97K to 43.97K |
